Takeda Expects Swing to Profit as Shire Integration Gains Pace

(Bloomberg) -- Takeda Pharmaceutical Co.’s integration of its $62 billion purchase of Shire Plc is netting faster savings than expected, leading Japan’s largest drugmaker to expect an annual profit...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.